196 related articles for article (PubMed ID: 32228921)
1. Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed.
Almáši M; Beňová E; Zeleňák V; Madaj B; Huntošová V; Brus J; Urbanová M; Bednarčík J; Hornebecq V
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110552. PubMed ID: 32228921
[TBL] [Abstract][Full Text] [Related]
2. Adsorption and Release Properties of Drug Delivery System Naproxen-SBA-15: Effect of Surface Polarity, Sodium/Acid Drug Form and
Zauška Ľ; Beňová E; Urbanová M; Brus J; Zeleňák V; Hornebecq V; Almáši M
J Funct Biomater; 2022 Dec; 13(4):. PubMed ID: 36547535
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release.
Rehman F; Rahim A; Airoldi C; Volpe PLO
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive Drug Delivery System SBA-15-PEI for Controlled Release of Nonsteroidal Anti-Inflammatory Drug Diclofenac Sodium Salt: A Comparative Study.
Zauska L; Bova S; Benova E; Bednarcik J; Balaz M; Zelenak V; Hornebecq V; Almasi M
Materials (Basel); 2021 Apr; 14(8):. PubMed ID: 33918907
[TBL] [Abstract][Full Text] [Related]
5. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
6. Surface engineered mesoporous silica carriers for the controlled delivery of anticancer drug 5-fluorouracil: Computational approach for the drug-carrier interactions using density functional theory.
Rehman F; Khan AJ; Sama ZU; Alobaid HM; Gilani MA; Safi SZ; Muhammad N; Rahim A; Ali A; Guo J; Arshad M; Emran TB
Front Pharmacol; 2023; 14():1146562. PubMed ID: 37124235
[No Abstract] [Full Text] [Related]
7. In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices.
Alexa IF; Ignat M; Popovici RF; Timpu D; Popovici E
Int J Pharm; 2012 Oct; 436(1-2):111-9. PubMed ID: 22743006
[TBL] [Abstract][Full Text] [Related]
8. Functionalized silica nanoparticles as a carrier for Betamethasone Sodium Phosphate: Drug release study and statistical optimization of drug loading by response surface method.
Ghasemnejad M; Ahmadi E; Mohamadnia Z; Doustgani A; Hashemikia S
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():223-32. PubMed ID: 26249584
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured SBA-15 host applied in ketorolac tromethamine release system.
Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA
J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001
[TBL] [Abstract][Full Text] [Related]
10. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
Song SW; Hidajat K; Kawi S
Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
[TBL] [Abstract][Full Text] [Related]
11. Preparation and physical characterization of calcium sulfate cement/silica-based mesoporous material composites for controlled release of BMP-2.
Tan H; Yang S; Dai P; Li W; Yue B
Int J Nanomedicine; 2015; 10():4341-50. PubMed ID: 26185438
[TBL] [Abstract][Full Text] [Related]
12. Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery.
Shen S; Chow PS; Chen F; Tan RB
Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):985-91. PubMed ID: 17603186
[TBL] [Abstract][Full Text] [Related]
13. The applicability of ordered mesoporous SBA-15 and its hydrophobic glutaraldehyde-bridge derivative to improve ibuprofen-loading in releasing system.
Rehman F; Volpe PL; Airoldi C
Colloids Surf B Biointerfaces; 2014 Jul; 119():82-9. PubMed ID: 24819430
[TBL] [Abstract][Full Text] [Related]
14. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.
Nairi V; Medda L; Monduzzi M; Salis A
J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049
[TBL] [Abstract][Full Text] [Related]
15. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
16. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
18. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
[TBL] [Abstract][Full Text] [Related]
19. Adsorption of lysozyme on hyaluronic acid functionalized SBA-15 mesoporous silica: a possible bioadhesive depot system.
Medda L; Casula MF; Monduzzi M; Salis A
Langmuir; 2014 Nov; 30(43):12996-3004. PubMed ID: 25295387
[TBL] [Abstract][Full Text] [Related]
20. Organically functionalized mesoporous SBA-15 as sorbents for removal of selected pharmaceuticals from water.
Bui TX; Kang SY; Lee SH; Choi H
J Hazard Mater; 2011 Oct; 193():156-63. PubMed ID: 21840644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
